D'AMICO, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 20.254
EU - Europa 9.790
AS - Asia 2.387
SA - Sud America 489
OC - Oceania 78
AF - Africa 63
Continente sconosciuto - Info sul continente non disponibili 11
Totale 33.072
Nazione #
US - Stati Uniti d'America 20.024
GB - Regno Unito 3.785
IT - Italia 1.953
SE - Svezia 1.129
CN - Cina 880
DE - Germania 691
HK - Hong Kong 617
UA - Ucraina 436
IE - Irlanda 377
TR - Turchia 298
FI - Finlandia 294
BG - Bulgaria 227
ES - Italia 225
FR - Francia 223
PE - Perù 135
IN - India 132
BE - Belgio 131
CA - Canada 123
CO - Colombia 104
BR - Brasile 95
MX - Messico 82
IR - Iran 77
AU - Australia 69
KR - Corea 65
NL - Olanda 64
VN - Vietnam 64
CL - Cile 63
MY - Malesia 56
EC - Ecuador 54
RU - Federazione Russa 52
PT - Portogallo 38
JP - Giappone 32
SG - Singapore 28
AR - Argentina 26
CH - Svizzera 25
RO - Romania 24
ID - Indonesia 22
PH - Filippine 19
CZ - Repubblica Ceca 18
NO - Norvegia 17
TW - Taiwan 16
PK - Pakistan 14
SA - Arabia Saudita 14
ZA - Sudafrica 14
GR - Grecia 13
EG - Egitto 10
HU - Ungheria 10
NG - Nigeria 10
MK - Macedonia 9
NZ - Nuova Zelanda 9
PL - Polonia 9
PR - Porto Rico 9
DK - Danimarca 8
IQ - Iraq 8
AT - Austria 7
AL - Albania 6
BD - Bangladesh 6
BO - Bolivia 6
BZ - Belize 6
IL - Israele 6
RS - Serbia 6
TH - Thailandia 6
GH - Ghana 5
VE - Venezuela 5
EU - Europa 4
KE - Kenya 4
OM - Oman 4
SI - Slovenia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BF - Burkina Faso 3
CD - Congo 3
CU - Cuba 3
CY - Cipro 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
LB - Libano 3
MA - Marocco 3
MO - Macao, regione amministrativa speciale della Cina 3
SY - Repubblica araba siriana 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
BJ - Benin 2
DZ - Algeria 2
HR - Croazia 2
LK - Sri Lanka 2
PA - Panama 2
AD - Andorra 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
AW - Aruba 1
EE - Estonia 1
GP - Guadalupe 1
JO - Giordania 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
MT - Malta 1
MV - Maldive 1
Totale 33.063
Città #
Fairfield 3.192
Southend 2.655
Woodbridge 1.929
Houston 1.763
Ashburn 1.583
Chandler 1.579
Seattle 1.162
Cambridge 1.034
Wilmington 983
Ann Arbor 918
Jacksonville 909
Nyköping 855
Dearborn 824
Hong Kong 588
Modena 439
Beijing 424
Dublin 365
San Diego 337
Princeton 255
New York 239
Sofia 227
Eugene 174
Helsinki 147
London 145
Izmir 144
Brussels 125
Milan 120
Bremen 93
Lima 90
Redwood City 80
Bologna 78
Des Moines 72
Fremont 71
Rome 69
Norwalk 62
Shanghai 57
Boardman 53
Ottawa 53
Dong Ket 50
Falls Church 49
Madrid 34
Parma 34
Kilburn 33
Hefei 32
Bogotá 31
Quito 29
San Jose 28
Nanjing 27
Reggio Emilia 27
Santiago 27
San Francisco 26
Turin 25
Grafing 23
Medellín 23
Seongnam 23
Sydney 21
Verona 21
Chiswick 20
Hounslow 20
Prescot 20
Guangzhou 19
Paris 19
Phoenix 19
Trujillo 19
Chicago 18
Frankfurt am Main 18
Toronto 18
Leawood 17
San Mateo 16
Dongguan 15
Fort Worth 15
Padova 15
Perozinho 15
Perugia 15
Seoul 15
Valencia 15
Groningen 14
Kunming 14
Mountain View 14
Munich 14
Philadelphia 14
Indiana 13
Central 12
Florence 12
Piacenza 12
Rimini 12
San Giuliano Milanese 12
Shenyang 12
Bari 11
Guayaquil 11
Naples 11
Saint Petersburg 11
Augusta 10
Dallas 10
Hanoi 10
Islington 10
Melbourne 10
Naucalpan 10
Vigo 10
Washington 10
Totale 25.063
Nome #
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement 1.508
Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective Study 506
Evaluating non-randomised intervention studies 445
VALORE PROGNOSTICO E PREDITTIVO DI p53 NEL CARCINOMA MAMMARIO TRATTATO CON CHEMIOTERAPIA NEOADIUVANTE 391
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 343
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis 298
GD2 expression in breast cancer. 285
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 274
Non-steroid agents for idiopathic pulmonary fibrosis 259
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 254
Pectoralis Muscle Transposition in Association with the Ravitch Procedure in the Management of Severe Pectus Excavatum. 245
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 242
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 231
A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score 226
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 224
Up-regulation of the canonical Wnt-3A and Sonic hedgehog signaling underlies melanocortin-induced neurogenesis after cerebral ischemia 219
Prenatal education for congenital toxoplasmosis 207
Effect of expert-patient teaching on empathy in nursing students: a randomized controlled trial 205
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II-III Breast Cancer 204
Analgesia during abdominal aortic aneurysm endovascular repair: remifentanil vs fentanyl-midazolam - a randomized controlled trial 202
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 199
Home care for heart failure: can caregiver education prevent hospital admissions? A randomized trial in primary care 198
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV 195
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 193
Short-term and long-term effects of tibolone in postmenopausal women 192
CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption. 192
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.. 191
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 191
Novel genetic association of TNF-α-238 and PDCD1-7209 polymorphisms with long-term non-progressive HIV-1 infection. 191
Decreased mitochondrial DNA content in subcutaneous fat from HIV-infected women taking antiretroviral therapy as measured at delivery. 191
Prevalence and Risk Factors of PTSD in Children and Adolescents after the 2012 Earthquake in the Emilia Romagna Region: implications for intervention 190
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome. 189
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER 188
Selenium for preventing cancer 188
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure. 188
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy. 188
Are parents of children hospitalized with severe community-acquired pneumonia more satisfied with care when physicians allow them to share decisions on the antibiotic route? 185
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis 185
Antibiotic Prophylaxis to Reduce Respiratory Tract Infections and Mortality in Adults Receiving Intensive Care 185
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis 185
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. 184
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 182
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 181
Prognostic value of diffusion-weighted imaging summation scores or apparent diffusion coefficient maps in newborns with hypoxic-ischemic encephalopathy 180
Final results of a phase II randomized trial of neoadjuvant anthracycline-taxane chemotherapy plus lapatinib, trastuzumab, or both in HER2-positive breast cancer (CHER-LOB trial). 180
Prevalence and risk factors of Post-Traumatic Stress Disorder in children and adolescents after the 2012 earthquake affecting the Emilia Romagna Region (Italy). 180
Major discrepancies between what clinical trial registries record and paediatric randomised controlled trials publish 180
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 180
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 179
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. 179
The effect of potassium supplementation on blood pressure in hypertensive subjects: A systematic review and meta-analysis. 178
Predictive Value of Intracellular HIV-1 DNA Levels During CD4-Guided Treatment Interruption in HIV(+) Patients 177
Discordances originated by multiple meta-analyses on interventions for myocardial infarction: a systematic review 176
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 173
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 173
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 172
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 171
GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a Modified Atkins Diet in Autosomal Dominant Polycystic Kidney Disease patients 170
Pain and emotional distress in leukemia patients at diagnosis. 169
Systematic review of maternal voice interventions demonstrates increased stability in preterm infants 169
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 169
Amantadine for fatigue in multiple sclerosis 169
Commentary: The debate on non-inferiority trials: ' when meta-analysis alone is not helpful' 168
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 168
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration 167
Short-Term Efficacy of Upper-Extremity Exercise Training in Patients With Chronic Airway Obstruction: A Systematic Review. 167
Chronic total coronary occlusion in patients with intermediate viability: value of low-dose dobutamine and contrast-enhanced 3-T MRI in predicting functional recovery in patients undergoing percutaneous revascularisation with drug-eluting stent. 166
Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction 165
Cyclophosphamide for multiple sclerosis 164
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial. 164
Trastuzumab containing regimens for early breast cancer. 164
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 164
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 163
Antibiotics for preventing respiratory tract infections in adults receiving intensive care 163
Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer 162
Antithrombin plasma levels decrease is associated with preeclampsia worsening. 160
Trastuzumab-containing regimens for metastatic breast cancer 160
3* Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer 160
Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling. 160
Streptococcus salivarius by nasal spray for recurrent otitis: how good is the evidence? 159
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 159
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 158
Motor and Postural Patterns Concomitant with General Movements Are Associated with Cerebral Palsy at Term and Fidgety Age in Preterm Infants 156
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 156
Early inspiratory effort assessment by esophageal manometry early predicts noninvasive ventilation outcome in de novo respiratory failure: a pilot study. 156
A prognostic model based on nodal status and Ki 67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy 155
Antibiotic prophylaxis in intensive care units: meta-analyses versus clinical practice 154
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 154
The diagnostic reliability of urinary cytology: A retrospective study. 153
Selenium for preventing cancer. 153
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): A structured summary of a study protocol 153
Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer 152
One model, several results: the paradox of the Hosmer-Lemeshow goodness-of-fit test for the logistic regression model 152
Preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2 positive operable breast cancer: results of the randomized phase II CHER-LOB study 151
Antibiotic prophylaxis to prevent nosocomial infections in patients in intensive care units: evidence that struggle to convince practising clinicians 150
Does needle calibre affect pain and complication rates in patients undergoing transperineal prostate biopsy? A prospective, randomized trial 150
Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care 148
Indirect comparisons of competing interventions 147
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 147
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 145
Totale 20.436
Categoria #
all - tutte 126.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.585


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.190 0 0 0 0 0 0 0 46 95 280 676 1.093
2019/20206.629 526 250 189 390 759 1.159 1.103 730 621 275 366 261
2020/20216.280 457 253 568 566 847 510 419 714 351 705 589 301
2021/20224.950 348 538 447 213 123 276 282 250 534 440 912 587
2022/20236.654 658 666 418 496 614 698 199 566 1.001 669 339 330
2023/20243.401 282 290 297 386 667 493 477 509 0 0 0 0
Totale 33.517